Abstract:figure legend Whole cell patch clamp electrophysiology using in vitro spinal cord slices demonstrated that spinal motoneurons (MNs) from neonatal rabbits subjected to hypoxia‐ischaemia (HI) in utero were more responsive to modulation by 5‐HT than MNs from age‐matched typically developing rabbits. Immunostaining determined that fewer MNs expressed inhibitory 5‐HT1A receptors in HI rabbits compared to control rabbits, which could contribute to the more robust excitatory response of HI MNs to 5‐HT. Created with BioRender.com. Cerebral palsy (CP) is caused by a variety of factors that damage the developing central nervous system. Impaired motor control, including muscle stiffness and spasticity, is the hallmark of spastic CP. Rabbits that experience hypoxic‐ischaemic (HI) injury in utero (at 70%–83% gestation) are born with muscle stiffness, hyperreflexia and, as recently discovered, increased 5‐HT in the spinal cord. To determine whether serotonergic modulation of spinal motoneurons (MNs) contributes to motor deficits, we performed ex vivo whole cell patch clamp in neonatal rabbit spinal cord slices at postnatal day (P) 0–5. HI MNs responded to the application of α‐methyl 5‐HT (a 5‐HT1/5‐HT2 receptor agonist) and citalopram (a selective 5‐HT reuptake inhibitor) with increased amplitude and hyperpolarization of persistent inward currents and hyperpolarized threshold voltage for action potentials, whereas control MNs did not exhibit any of these responses. Although 5‐HT similarly modulated MN properties of HI motor‐unaffected and motor‐affected kits, it affected sag/hyperpolarization‐activated cation current (Ih) and spike frequency adaptation only in HI motor‐affected MNs. To further explore the differential sensitivity of MNs to 5‐HT, we performed immunostaining for inhibitory 5‐HT1A receptors in lumbar spinal MNs at P5. Fewer HI MNs expressed the 5‐HT1A receptor compared to age‐matched control MNs. This suggests that HI MNs may lack a normal mechanism of central fatigue, mediated by 5‐HT1A receptors. Altered expression of other 5‐HT receptors (including 5‐HT2) likely also contributes to the robust increase in HI MN excitability. In summary, by directly exciting MNs, the increased concentration of spinal 5‐HT in HI‐affected rabbits can cause MN hyperexcitability, muscle stiffness and spasticity characteristic of CP. Therapeutic strategies that target serotonergic neuromodulation may be beneficial to individuals with CP. Key points We used whole cell patch clamp electrophysiology to test the responsivity of spinal motoneurons (MNs) from neonatal control and hypoxia‐ischaemia (HI) rabbits to 5‐HT, which is elevated in the spinal cord after prenatal HI injury. HI rabbit MNs showed a more robust excitatory response to 5‐HT than control rabbit MNs, including hyperpolarization of the persistent inward current and threshold voltage for action potentials. Although most MN properties of HI motor‐unaffected and motor‐affected kits responded similarly to 5‐HT, 5‐HT caused larger sag/hyperpolarization‐activated cation current (Ih) and altered repetitive firing patterns only in HI motor‐affected MNs. Immunostaining revealed that fewer lumbar MNs expressed inhibitory 5‐HT1A receptors in HI rabbits compared to controls, which could account for the more robust excitatory response of HI MNs to 5‐HT. These results suggest that elevated 5‐HT after prenatal HI injury could trigger a cascade of events that lead to muscle stiffness and altered motor unit development.

Human motoneurone excitability is depressed by activation of serotonin 1A receptors with buspirone

Buspirone-induced Antinociception is Mediated by L-Type Calcium Channels and Calcium/caffeine-Sensitive Pools in Mice

Modulation of motoneuron activity by serotonin

Opposing effects of 5-HT1A receptor agonist buspirone on supraspinal abdominal pain transmission in normal and visceral hypersensitive rats

Serotonergic and noradrenergic contributions to human motor cortical and spinal motoneuronal excitability

Facilitation of Locomotor Spinal Networks Activity by Buspirone after a Complete Spinal Cord Lesion in Mice

Serotonergic and noradrenergic contributions to motor cortical and spinal motoneuronal excitability in humans

Buspirone alleviates anxiety, depression, and colitis; and modulates gut microbiota in mice

Antagonism of 5‐HT2 receptors attenuates self‐sustained firing of human motor units

Serotonergic Facilitation of Forelimb Functional Recovery in Rats with Cervical Spinal Cord Injury

Buspirone for functional improvement after acute traumatic spinal cord injury: a propensity score-matched cohort study

Effects of acute and chronic buspirone on impulsive choice and efflux of 5-HT and dopamine in hippocampus, nucleus accumbens and prefrontal cortex

Buspirone Induces Weight Loss and Normalization of Blood Pressure Via the Stimulation of PPARδ Dependent Energy Producing Pathway in Spontaneously Hypertensive Rats

Assessing the Anti-Inflammatory Activity of the Anxiolytic Drug Buspirone Using CRISPR-Cas9 Gene Editing in LPS-Stimulated BV-2 Microglial Cells

Modification of serotonin neuron properties in mice lacking 5-HT1A receptors

Spinal motoneurons respond aberrantly to serotonin in a rabbit model of cerebral palsy

Effects of Subchronic Buspirone Treatment on Depressive Profile in Socially Isolated Rats: Implication of Early Life Experience on 5-HT1A Receptor-Related Depression

Lack of Deleterious Effects of Buspirone on Cognition in Healthy Male Volunteers

Systemic serotonin inhibits brown adipose tissue sympathetic nerve activity via a GABA input to the dorsomedial hypothalamus, not via 5HT1A receptor activation in raphe pallidus

Minimal handgrip force is needed for transcutaneous electrical stimulation to improve hand functions of patients with severe spinal cord injury

Conservation of 5-HT1A receptor-mediated autoinhibition of serotonin (5-HT) neurons in mice with altered 5-HT homeostasis